Bullish option flow detected in Teva (TEVA) with 17,095 calls trading, 1.7x expected, and implied vol increasing over 1 point to 42.32%. 3/14 weekly 17 calls and 3/14 weekly 16.5 calls are the most active options, with total volume in those strikes near 13,600 contracts. The Put/Call Ratio is 0.13. Earnings are expected on May 7th.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEVA:
- Teva price target lowered to $20 from $23 at BofA
- Teva, Medincell announce FDA acceptance of sNDA for Uzedy
- FDA accepts Teva & Medincell’s UZEDY sNDA for extended-release to treat BP-I
- Teva Pharmaceutical’s Promising TL1a Program Drives Buy Rating Amid Strong Phase 2 Data for Duvakitug
- Teva holds a pharmaceutical update conference call